Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2915 ARTíCULOS , VIENDO DEL 1 AL 15

PUBMED

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators..

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

0

0

0

PUBMED

Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.

Lee HM, Koh SB.

J Mov Disord. 2015 May;8(2):92-7. doi: 10.14802/jmd.15003. Review.

0

0

0

PUBMED

Exercise Effects on Early Vocal Ultrasonic Communication Dysfunction in a PINK1 Knockout Model of Parkinson's Disease.

Kelm-Nelson CA, Yang KM, Ciucci MR.

J Parkinsons Dis. 2015;5(4):749-63. doi: 10.3233/JPD-150688.

0

0

0

PUBMED

The genetics of Parkinson's disease.

Mullin S, Schapira A.

Br Med Bull. 2015 Jun;114(1):39-52. doi: 10.1093/bmb/ldv022. Review.

0

0

0

PUBMED

Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.

Solla P, Fasano A, Cannas A, Marrosu F.

Mov Disord. 2015 Nov;30(13):1859-60. doi: 10.1002/mds.26443. No abstract available.

0

0

0

PUBMED

Preoperative brain metabolism and quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Langner-Lemercier S, Drapier S, Naudet F, Le Clanche N, Houvenaghel JF, Sauleau P, Jannin P, Haegelen C, Le Jeune F, Vérin M.

J Neurol. 2015;262(4):881-9. doi: 10.1007/s00415-015-7647-1.

0

0

0

PUBMED

The medical treatment of Parkinson disease from James Parkinson to George Cotzias.

Fahn S.

Mov Disord. 2015 Jan;30(1):4-18. doi: 10.1002/mds.26102. Review.

0

0

0

PUBMED

[The use of piribedil in early and late stages of Parkinson's disease].

Fedorova NV, Kulua TK, Gubanova ЕN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(10):96-8. Russian.

0

0

0

PUBMED

[Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease].

Rodríguez-Violante M, Velázquez-Osuna S, Cervantes-Arriaga A, Corona-Vázquez T, de la Fuente-Sandoval C.

Gac Med Mex. 2015 Mar-Apr;151(2):169-75. Spanish.

0

0

0

PUBMED

Neuroimaging of Parkinson's disease: Expanding views.

Weingarten CP, Sundman MH, Hickey P, Chen NK.

Neurosci Biobehav Rev. 2015 Dec;59:16-52. doi: 10.1016/j.neubiorev.2015.09.007. Review.

0

0

0

PUBMED

Colonic mucosal a-synuclein lacks specificity as a biomarker for Parkinson disease.

Visanji NP, Marras C, Kern DS, Al Dakheel A, Gao A, Liu LW, Lang AE, Hazrati LN.

Neurology. 2015 Feb 10;84(6):609-16.

0

0

0

PUBMED

Decreased dopaminergic treatment of hospitalized Parkinson's disease patients during infectious diseases is associated with poor outcomes.

Segal O, Hassin-Baer S, Rosman M, Segal G.

J Clin Neurosci. 2015 Aug;22(8):1272-4. doi: 10.1016/j.jocn.2015.02.010.

0

0

0

PUBMED

Challenging Postural Tasks Increase Asymmetry in Patients with Parkinson's Disease.

Beretta VS, Gobbi LT, Lirani-Silva E, Simieli L, Orcioli-Silva D, Barbieri FA.

PLoS One. 2015 Sep 14;10(9):e0137722. doi: 10.1371/journal.pone.0137722.

0

0

0

PUBMED

Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.

Shine JM, Keogh R, O'Callaghan C, Muller AJ, Lewis SJ, Pearson J.

Proc Biol Sci. 2015 Jan 7;282(1798):20142047. doi: 10.1098/rspb.2014.2047.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy